GET DAILY SIGNALSGentherm (THRM) Reports Q3 Revenue Growth but Faces Margin and EPS Pressure
Key Takeaways
- Product revenue reached $405.1 million, up 4.7% year over year, narrowly topping consensus estimates of roughly $404 million.
- Adjusted diluted earnings per share (EPS) came in at $0.33, well below the consensus of about $0.65, driven by higher tax rates tied to deal costs.
- Gross margin slipped to 23.3% from 24.6% a year earlier on foreign exchange, material costs, and inflation.
- The company completed its combination with Modine Performance Technologies on October 1 and raised full-year 2026 revenue and adjusted EBITDA guidance.
- Gentherm repurchased $60 million of stock in October, with about $340 million remaining under its buyback authorization.
Why the Quarter Matters
Gentherm (THRM), a provider of thermal and precision flow management technologies, posted third-quarter results that show ongoing commercial progress alongside clear margin challenges. This report carries extra weight as the first one following the close of its combination with Modine Performance Technologies, which broadens the company’s exposure beyond automotive seats into power generation, commercial vehicles, and heavy-duty equipment. From what I see, investors are focused on whether the core automotive business can continue to outpace market growth while management works through transaction costs, inflation, and currency effects. With new business awards holding steady and full-year guidance lifted, the quarter points to a company navigating change rather than standing still.
The Numbers in Detail
For the third quarter ended September 30, 2026, Gentherm reported product revenue of $405.1 million, a 4.7% increase from $386.9 million a year earlier and a 4.4% gain excluding foreign currency translation. Revenue edged past analyst estimates of about $404 million. Automotive Climate and Comfort Solutions revenue climbed 8.8% to $346.4 million, beating light vehicle production in relevant markets by 12 percentage points, while the Medical segment rose 14.6% to $14.5 million.
Profitability proved the softer area. Adjusted diluted EPS was $0.33, missing the consensus of roughly $0.65 by $0.32 and down from $0.73 in the prior-year quarter. On a GAAP basis, the company recorded a net loss of $2.6 million, or $0.08 per diluted share, compared with net income of $14.9 million, or $0.49 per share, a year ago. The drop reflected merger and restructuring expenses of about $0.37 per share and a higher tax rate linked to the timing of M&A costs.
Adjusted EBITDA totaled $45.0 million, or 11.1% of revenue, down from $49.0 million, or 12.7%, in the prior-year period. Gross margin declined to 23.3% from 24.6%, pressured by foreign exchange, higher net material costs, and inflation. Operating cash flow fell to $36.0 million from $87.8 million, while adjusted free cash flow was $59.5 million versus $72.3 million a year ago.
Management raised full-year 2026 guidance to include the Modine contribution: product revenue of $1.825 billion to $1.925 billion, adjusted EBITDA of $210 million to $230 million, and adjusted free cash flow of $100 million to $120 million.
Market Reaction
Shares of Gentherm fell sharply after the release, dropping about 7% in early trading as investors focused on the earnings miss rather than the revenue beat. The stock had already declined more than 20% over the prior twelve months, and the report moved it toward the lower end of its recent range. The reaction indicates the market was surprised by the size of the adjusted EPS shortfall and margin compression, even though management described results as in line with expectations. Strong automotive award momentum and raised guidance offered some offset, but near-term sentiment stays cautious amid ongoing cost pressures and integration risks.
What to Watch Going Forward
After this report, attention turns to the integration of Modine Performance Technologies and the company’s ability to turn its larger scale into improved margins. Management outlined a path to more than $3.5 billion in revenue and over $500 million in adjusted EBITDA by 2030, along with a $25 million cost synergy target from the combination.
Several items deserve monitoring in upcoming quarters. First, observe whether freight and material cost inflation moderates, as these drove the margin decline. Second, follow the pace of customer cost-recovery negotiations, which management noted could require time. Third, track the integration of Modine’s power generation, commercial vehicle, and heavy-duty equipment businesses, including the expected fourth-quarter contribution.
On the demand side, the company secured $555 million in automotive new business awards during the quarter, bringing the year-to-date total above $1.6 billion and keeping it on pace for a fourth straight year of at least $2 billion. New initiatives, including the ThermAffyx patient safety system, home and office expansion, and an initial air-moving device award in India, provide further growth options. Capital allocation also remains relevant, with Gentherm indicating it will stay active on share repurchases in the fourth quarter given its view that the stock is undervalued. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Using Tickeron’s AI Screener in Practice
When I review earnings releases like this one, I often run a quick screen with Tickeron’s AI Screener to place the results in broader context and spot comparable names in the sector. It lets me filter by industry, performance metrics, and technical signals without spending hours on manual work, which helps me stay focused on the key variables that matter for the investment case.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
THRM sees MACD Histogram just turned negative
THRM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 36 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 80%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where THRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for THRM entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where THRM's RSI Indicator exited the oversold zone, 26 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where THRM advanced for three days, in 173 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
THRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.209) is normal, around the industry mean (0.880). P/E Ratio (32.690) is within average values for comparable stocks, (39.798). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (1.471). THRM's Dividend Yield (0.291) is considerably higher than the industry average of (0.039). P/S Ratio (0.746) is also within normal values, averaging (49.084).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. THRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of automotive parts
Industry AutoPartsOEM
Advertisement